Is there still a place for vasopressors in the treatment of cardiac arrest?

Critical Care

Volumn 16, Issue 2, 2012, Pages

  Sandroni, Claudio ^a   Cavallaro, Fabio ^a   Antonelli, Massimo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; HYDROCORTISONE SODIUM SUCCINATE; HYPERTENSIVE FACTOR; VASOPRESSIN; VASOCONSTRICTOR AGENT; VASOPRESSIN DERIVATIVE;

ASYSTOLE; DEFIBRILLATION; DRUG HALF LIFE; DRUG MECHANISM; HEART ARREST; PRIORITY JOURNAL; RESUSCITATION; RETURN OF SPONTANEOUS CIRCULATION; REVIEW; ANIMAL; CLINICAL TRIAL (TOPIC); HUMAN; OUTCOME ASSESSMENT;

ANIMALS; CLINICAL TRIALS AS TOPIC; EPINEPHRINE; HEART ARREST; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 84858745387     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11227     Document Type: Review

References (42)

1. McNally B, Robb R, Mehta M, et al. Out-of-Hospital Cardiac Arrest Surveillance- Cardiac Arrest Registry to Enhance Survival (CARES), United States, October 1, 2005-December 31, 2010. MMWR Surveill Summ 2011, 60(8):1-19.
2. Sandroni C, Nolan J, Cavallaro F, Antonelli M. In-hospital cardiac arrest: incidence, prognosis and possible measures to improve survival. Intensive Care Med 2007, 33:237-245. 10.1007/s00134-006-0326-z, 17019558.
3. Sasson C, Rogers MA, Dahl J, Kellermann AL. Predictors of survival from out-of-hospital cardiac arrest: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes 2010, 3:63-81. 10.1161/CIRCOUTCOMES.109.889576, 20123673.
4. Stiell IG, Wells GA, Field B, et al. Advanced cardiac life support in out-of-hospital cardiac arrest. N Engl J Med 2004, 351:647-656. 10.1056/NEJMoa040325, 15306666.
5. Deakin CD, Nolan JP, Soar J, et al. European Resuscitation Council Guidelines for Resuscitation 2010 Section 4. Adult advanced life support. Resuscitation 2010, 81:1305-1352. 10.1016/j.resuscitation.2010.08.017, 20956049.
6. Kern KB, Ewy GA, Voorhees WD, Babbs CF, Tacker WA. Myocardial perfusion pressure: a predictor of 24-hour survival during prolonged cardiac arrest in dogs. Resuscitation 1988, 16:241-250. 10.1016/0300-9572(88)90111-6, 2849790.
7. Brown CG, Katz SE, Werman HA, Luu T, Davis EA, Hamlin RL. The effect of epinephrine versus methoxamine on regional myocardial blood flow and defibrillation rates following a prolonged cardiorespiratory arrest in a swine model. Am J Emerg Med 1987, 5:362-369. 10.1016/0735-6757(87)90382-2, 3620033.
8. Paradis NA, Martin GB, Rivers EP, et al. Coronary perfusion pressure and the return of spontaneous circulation in human cardiopulmonary resuscitation. JAMA 1990, 263:1106-1113. 10.1001/jama.1990.03440080084029, 2386557.
9. Neumar RW, Otto CW, Link MS, et al. Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010, 122:S729-S767. 10.1161/CIRCULATIONAHA.110.970988, 20956224.
10. Schumann HJ. What role do alpha- and beta-adrenoceptors play in the regulation of the heart?. Eur Heart J 1983, 4(Suppl A):55-60.
11. Ditchey RV, Lindenfeld J. Failure of epinephrine to improve the balance between myocardial oxygen supply and demand during closed-chest resuscitation in dogs. Circulation 1988, 78:382-389. 10.1161/01.CIR.78.2.382, 3396175.
12. Brown AM, Birnbaumer L. Direct G protein gating of ion channels. Am J Physiol 1988, 254:H401-H410.
13. Meissner A, Morgan JP. Contractile dysfunction and abnormal Ca2+ modulation during postischemic reperfusion in rat heart. Am J Physiol 1995, 268:H100-H111.
14. Gonzalez MM, Berg RA, Nadkarni VM, et al. Left ventricular systolic function and outcome after in-hospital cardiac arrest. Circulation 2008, 117:1864-1872. 10.1161/CIRCULATIONAHA.107.740167, 18378611.
15. Laurent I, Monchi M, Chiche JD, et al. Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest. J Am Coll Cardiol 2002, 40:2110-2116. 10.1016/S0735-1097(02)02594-9, 12505221.
16. Tang W, Weil MH, Sun S, Noc M, Yang L, Gazmuri RJ. Epinephrine increases the severity of postresuscitation myocardial dysfunction. Circulation 1995, 92:3089-3093.
17. Ristagno G, Tang W, Huang L, et al. Epinephrine reduces cerebral perfusion during cardiopulmonary resuscitation. Crit Care Med 2009, 37:1408-1415. 10.1097/CCM.0b013e31819cedc9, 19242339.
18. Lindner KH, Strohmenger HU, Ensinger H, Hetzel WD, Ahnefeld FW, Georgieff M. Stress hormone response during and after cardiopulmonary resuscitation. Anesthesiology 1992, 77:662-668. 10.1097/00000542-199210000-00008, 1329579.
19. Zhong JQ, Dorian P. Epinephrine and vasopressin during cardiopulmonary resuscitation. Resuscitation 2005, 66:263-269. 10.1016/j.resuscitation.2005.02.014, 16039036.
20. Krismer AC, Lindner KH, Wenzel V, et al. The effects of endogenous and exogenous vasopressin during experimental cardiopulmonary resuscitation. Anesth Analg 2001, 92:1499-1504.
21. Lindner KH, Prengel AW, Pfenninger EG, et al. Vasopressin improves vital organ blood flow during closed-chest cardiopulmonary resuscitation in pigs. Circulation 1995, 91:215-221.
22. Wenzel V, Lindner KH, Krismer AC, Miller EA, Voelckel WG, Lingnau W. Repeated administration of vasopressin but not epinephrine maintains coronary perfusion pressure after early and late administration during prolonged cardiopulmonary resuscitation in pigs. Circulation 1999, 99:1379-1384.
23. Wenzel V, Lindner KH, Prengel AW, et al. Vasopressin improves vital organ blood flow after prolonged cardiac arrest with postcountershock pulseless electrical activity in pigs. Crit Care Med 1999, 27:486-492. 10.1097/00003246-199903000-00022, 10199526.
24. Sirinek KR, Adcock DK, Levine BA. Simultaneous infusion of nitroglycerin and nitroprusside to offset adverse effects of vasopressin during portosystemic shunting. Am J Surg 1989, 157:33-37. 10.1016/0002-9610(89)90416-9, 2491934.
25. Prengel AW, Lindner KH, Keller A, Lurie KG. Cardiovascular function during the postresuscitation phase after cardiac arrest in pigs: a comparison of epinephrine versus vasopressin. Crit Care Med 1996, 24:2014-2019. 10.1097/00003246-199612000-00014, 8968270.
26. Lindner KH, Dirks B, Strohmenger HU, Prengel AW, Lindner IM, Lurie KG. Randomised comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation. Lancet 1997, 349:535-537. 10.1016/S0140-6736(97)80087-6, 9048792.
27. Stiell IG, Hebert PC, Wells GA, et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet 2001, 358:105-109. 10.1016/S0140-6736(01)05328-4, 11463411.
28. Wenzel V, Lindner KH. Vasopressin and epinephrine for cardiac arrest. Lancet 2001, 358:2080-2081.
29. Wenzel V, Krismer AC, Arntz HR, Sitter H, Stadlbauer KH, Lindner KH. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med 2004, 350:105-113. 10.1056/NEJMoa025431, 14711909.
30. Gueugniaud PY, David JS, Chanzy E, et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. N Engl J Med 2008, 359:21-30. 10.1056/NEJMoa0706873, 18596271.
31. Mentzelopoulos SD, Zakynthinos SG, Tzoufi M, et al. Vasopressin, epinephrine, and corticosteroids for in-hospital cardiac arrest. Arch Intern Med 2009, 169:15-24. 10.1001/archinternmed.2008.509, 19139319.
32. Sandroni C, Cavallaro F, Ferro G, et al. A survey of the in-hospital response to cardiac arrest on general wards in the hospitals of Rome. Resuscitation 2003, 56:41-47. 10.1016/S0300-9572(02)00283-6, 12505737.
33. Mentzelopoulos SD, Zakynthinos SG, Siempos I, Malachias S, Ulmer H, Wenzel V. Vasopressin for cardiac arrest: meta-analysis of randomized controlled trials. Resuscitation 2011, 83:32-39.
34. Olasveengen TM, Sunde K, Brunborg C, Thowsen J, Steen PA, Wik L. Intravenous drug administration during out-of-hospital cardiac arrest: a randomized trial. JAMA 2009, 302:2222-2229. 10.1001/jama.2009.1729, 19934423.
35. Jacobs IG, Finn JC, Jelinek GA, Oxer HF, Thompson PL. Effect of adrenaline on survival in out-of-hospital cardiac arrest: a randomised double-blind placebo-controlled trial. Resuscitation 2011, 82:1138-1143. 10.1016/j.resuscitation.2011.06.029, 21745533.
36. Laver S, Farrow C, Turner D, Nolan J. Mode of death after admission to an intensive care unit following cardiac arrest. Intensive Care Med 2004, 30:2126-2128. 10.1007/s00134-004-2425-z, 15365608.
37. Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002, 346:557-563. 10.1056/NEJMoa003289, 11856794.
38. The Hypothermia After Cardiac Arrest Study Group Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002, 346:549-556. The Hypothermia After Cardiac Arrest Study Group.
39. Merchant RM, Soar J, Skrifvars MB, et al. Therapeutic hypothermia utilization among physicians after resuscitation from cardiac arrest. Crit Care Med 2006, 34:1935-1940. 10.1097/01.CCM.0000220494.90290.92, 16691134.
40. Binks AC, Murphy RE, Prout RE, et al. Therapeutic hypothermia after cardiac arrest-implementation in UK intensive care units. Anaesthesia 2010, 65:260-265. 10.1111/j.1365-2044.2009.06227.x, 20085568.
41. Stub D, Bernard S, Duffy SJ, Kaye DM. Post cardiac arrest syndrome: a review of therapeutic strategies. Circulation 2011, 123:1428-1435. 10.1161/CIRCULATIONAHA.110.988725, 21464058.
42. Soar J, Packham S. Cardiac arrest centres make sense. Resuscitation 2010, 81:507-508. 10.1016/j.resuscitation.2010.01.017, 20303639.